New Endovascular Catheter Shows Unprecedented Ability to Treat Pulmonary Artery Obstruction
By HospiMedica International staff writers Posted on 20 Sep 2022 |

A breakthrough device significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, according to findings of a clinical study.
The new device known as the BASHIR Endovascular Catheter was developed by researchers at the Lewis Katz School of Medicine at Temple University (Philadelphia, PA, USA) in association with THROMBOLEX, Inc. (New Britain, PA, USA). The BASHIR catheter is made of an expandable basket with mini-infusion catheters. Once placed inside a clot, the infusion basket expands, creating new channels in the clot and thereby increasing the surface area exposed to clot-dissolving drugs delivered through the catheters. The greater exposure area accelerates clot breakdown and the restoration of blood flow through the vessel. A key clinical feature of the BASHIR catheter is its ability to shorten treatment duration.
Evidence for the performance of the BASHIR catheter comes from data collected in the RESCUE trial, a clinical study designed to evaluate the safety and efficacy of the catheter as a novel therapy for pulmonary embolism. The magnitude of reduction in the size of clots obstructing the pulmonary artery in the RESCUE trial was significantly greater than reductions reported for therapies currently used in the treatment of pulmonary embolism. The BASHIR catheter was approved by the U.S. Food and Drug Administration (FDA) in 2019 for the treatment of blood clots in veins and arteries in the peripheral vasculature. THROMBOLEX now has FDA clearance on seven devices in the BASHIR family of catheters, all of which are currently in commercialization.
“For the first time, we are able to show that this treatment not only leads to a remarkable reduction in pulmonary artery obstruction in patients with pulmonary embolism but also is a very safe therapy,” said Riyaz Bashir, MD, FACC, Professor of Medicine, Director of Vascular and Endovascular Medicine in the Section of Cardiology Department of Medicine, at the Lewis Katz school of Medicine and Temple University Hospital, and co-inventor of the BASHIR Endovascular Catheter.
“With existing devices, treatment by infusion of clot-dissolving drugs can last as long as 10 hours,” explained Vladimir Lakhter, DO, Assistant Professor of Medicine at the Lewis Katz School of Medicine and an interventional cardiologist involved in the RESCUE trial. “With the BASHIR device, infusion lasts only five hours. Once the device is removed, we are able to see a dramatic decrease in strain on the heart, bringing significant relief for patients.”
Related Links:
Temple University
THROMBOLEX, Inc.
Latest Surgical Techniques News
- Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
- New Surgical Technique Safely Removes Giant Nerve Tumors
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
- Novel Mechanical Heart Valve Improves Blood Flow and Lowers Risk of Blood Clots
- First-of-Its-Kind Device Replaces Mitral Valve Without Open-Heart Surgery
- Innovation in Thermographic Neurosurgical Imaging Supports Informed Decision-Making
- Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery
Channels
Surgical Techniques
view channel
Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
Aneurysms, especially when located in the brain, can be life-threatening if not treated effectively. Intracranial aneurysms, caused by the dilation of blood vessels due to weaknesses in the vessel wall,... Read more
New Surgical Technique Safely Removes Giant Nerve Tumors
Giant plexiform neurofibromas (PNF) are benign tumors commonly associated with neurofibromatosis Type 1 (NF1), a genetic disorder affecting approximately 1 in 3,000 live births. These tumors, which occur... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more